Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -4.29%261.36B | 1.65%1.05T | 14.14%273.08B | 11.44%1.04T | 18.46%308.92B | 4.08%245.43B | 8.29%244.21B | 14.38%239.26B | 5.94%931.29B | 16.10%260.79B |
| Cost of revenue | -3.10%172.52B | 0.61%720.55B | 10.77%178.05B | 7.07%716.16B | 13.48%221.32B | 0.11%166.66B | 5.83%167.44B | 7.78%160.74B | 4.62%668.87B | 12.38%195.04B |
| Gross profit | -6.52%88.84B | 3.97%334.43B | 21.03%95.03B | 22.57%321.66B | 33.23%87.6B | 13.60%78.77B | 14.09%76.77B | 30.77%78.52B | 9.45%262.42B | 28.73%65.75B |
| Operating expense | 1.97%56.53B | 1.85%230.94B | 2.66%55.44B | 4.10%226.75B | 7.23%61.95B | 0.94%55.04B | 2.79%55.76B | 5.33%54B | 4.61%217.82B | 6.18%57.78B |
| Operating profit | -18.41%32.31B | 9.04%103.49B | 61.50%39.6B | 112.77%94.91B | 221.70%25.64B | 60.22%23.73B | 61.04%21.02B | 179.44%24.52B | 41.40%44.61B | 338.72%7.97B |
| Net non-operating interest income (expenses) | -24.11%-2.48B | -8.49%-8.51B | 1.48%-2B | 2.93%-7.84B | 2.84%-1.92B | 5.28%-1.94B | 4.30%-1.96B | -0.75%-2.03B | -0.37%-8.08B | 17.89%-1.97B |
| Non-operating interest income | 67.23%199M | -2.84%547M | -13.14%119M | 35.66%563M | 0.87%116M | 30.00%143M | 72.16%167M | 47.31%137M | 32.59%415M | 129.56%115M |
| Non-operating interest expense | 26.54%2.68B | 7.73%9.05B | -2.22%2.11B | -1.05%8.4B | -2.63%2.03B | -3.48%2.08B | -0.84%2.13B | 2.81%2.16B | 1.58%8.49B | 3.67%2.09B |
| Net investment income | -5.58%558M | 45.43%1.62B | 14.09%591M | 5.58%1.12B | -8.29%199M | 25.19%169M | 13.30%230M | 3.19%518M | 11.50%1.06B | 0.93%217M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -86M | -37.54%930M | -85.05%45M | -71.58%27M | -95.28%30M | 80.79%828M | 28.14%1.49B | -65.99%301M | ||
| Income from associates and other participating interests | 79.57%5.12B | -4.73%11.76B | -37.30%2.85B | 31.57%12.34B | 6.56%4.09B | 42.23%1.3B | 4.07%2.4B | 96.12%4.55B | 84.29%9.38B | 341.26%3.84B |
| Special income (charges) | -115.86%-69M | 92.18%-385M | 400.00%435M | 34.07%-4.93B | 28.99%-3.97B | 82.24%-483M | -166.60%-327M | -141.55%-145M | 18.14%-7.47B | 73.79%-5.59B |
| Less:Other special charges | -64.06%69M | 57.28%-2.09B | -75.13%192M | -242.29%-4.89B | -3,473.40%-6.72B | -96.92%99M | 597.08%955M | 177.70%772M | 125.48%3.44B | 94.05%-188M |
| Less:Write off | --0 | -74.79%2.48B | 0.00%-627M | 143.38%9.82B | 84.93%10.69B | 178.21%384M | 0.00%-628M | 0.00%-627M | -82.17%4.03B | -76.41%5.78B |
| Other non-operating income (expenses) | -78.96%73M | 48.26%-638M | 201.74%347M | -405.96%-1.23B | -142.91%-1.42B | 60.63%-250M | -65.45%323M | -83.28%115M | -92.62%403M | -197.66%-585M |
| Income before tax | -15.30%35.43B | 13.75%107.34B | 47.47%41.83B | 128.02%94.37B | 420.32%21.74B | 113.76%22.55B | 39.38%21.71B | 156.00%28.36B | 53.10%41.39B | 117.04%4.18B |
| Income tax | -20.27%9.35B | -18.13%24.77B | 48.00%11.72B | 111.25%30.26B | 250.63%8.33B | 70.57%7.5B | 62.31%6.51B | 123.63%7.92B | -14.89%14.32B | 166.00%2.38B |
| Net income | -13.37%26.08B | 28.80%82.57B | 47.27%30.1B | 136.89%64.11B | 644.06%13.41B | 144.61%15.05B | 31.45%15.21B | 171.20%20.44B | 165.23%27.06B | 108.62%1.8B |
| Net income continuous operations | -13.36%26.08B | 28.80%82.57B | 47.27%30.1B | 136.89%64.11B | 644.06%13.41B | 144.64%15.05B | 31.43%15.21B | 171.21%20.44B | 165.23%27.06B | 108.62%1.8B |
| Noncontrolling interests | 216.47%788M | 1,589.47%2.89B | -47.69%249M | -83.94%171M | -1,023.08%-480M | -91.47%33M | -61.31%142M | 83.78%476M | -25.00%1.07B | -89.17%52M |
| Net income attributable to the company | -15.28%25.29B | 24.62%79.68B | 49.54%29.85B | 145.95%63.94B | 694.11%13.89B | 160.44%15.02B | 34.49%15.07B | 174.29%19.96B | 196.00%26B | 108.17%1.75B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -15.28%25.29B | 24.62%79.68B | 49.54%29.85B | 145.95%63.94B | 694.11%13.89B | 160.44%15.02B | 34.49%15.07B | 174.29%19.96B | 196.00%26B | 108.17%1.75B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -11.62%44.02 | 27.04%134.81 | 52.37%49.81 | 147.14%106.12 | 755.72%23.19 | 162.34%25.08 | 35.34%25.16 | 170.61%32.69 | 194.51%42.94 | 107.63%2.71 |
| Diluted earnings per share | -11.62%44.02 | 27.04%134.81 | 52.37%49.81 | 147.14%106.12 | 755.41%23.1817 | 162.26%25.0724 | 35.00%25.0967 | 170.61%32.69 | 194.51%42.94 | 107.63%2.71 |
| Dividend per share | 0 | 37.14%24 | 0 | 16.67%17.5 | 33.33%10 | 0 | 0.00%7.5 | 0 | 0.00%15 | 0.00%7.5 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |